Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samdeep Mouli

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Hepatology (Baltimore, Md.)|August 24, 2017
Radioembolization for hepatocellular carcinoma: Statistical confirmation of improved survival in responders by landmark analysesAhsun Riaz, Ahmed Gabr, Nadine Abouchaleh, et al.
Hepatology Communications|February 27, 2022
Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: Outcomes following liver transplantationAbhinav Talwar, Jeffrey Varghese, Gabriel M Knight, et al.
Hepatology (Baltimore, Md.)|May 22, 2021
TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard-of-Care TherapyGabriel M Knight, Jeffrey Clark, Justin R Boike, et al.
Radiology|April 25, 2018
Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular CarcinomaRobert J Lewandowski, Ahmed Gabr, Nadine Abouchaleh, et al.
Cardiovascular and Interventional Radiology|February 8, 2020
Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
Cardiovascular and Interventional Radiology|March 3, 2019
Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
Gastroenterology|August 31, 2016
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaRiad Salem, Andrew C Gordon, Samdeep Mouli, et al.
Cardiovascular and Interventional Radiology|April 7, 2021
Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient AnalysisMonica M Matsumoto, Samdeep Mouli, Priyali Saxena, et al.
Hepatology (Baltimore, Md.)|May 17, 2020
Liver Transplantation Following Yttrium-90 Radioembolization: 15-Year Experience in 207-Patient CohortAhmed Gabr, Laura Kulik, Samdeep Mouli, et al.
Hepatology (Baltimore, Md.)|December 2, 2017
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experienceRiad Salem, Ahmed Gabr, Ahsun Riaz, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Hepatology (Baltimore, Md.)|August 24, 2017
Radioembolization for hepatocellular carcinoma: Statistical confirmation of improved survival in responders by landmark analysesAhsun Riaz, Ahmed Gabr, Nadine Abouchaleh, et al.
Hepatology Communications|February 27, 2022
Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: Outcomes following liver transplantationAbhinav Talwar, Jeffrey Varghese, Gabriel M Knight, et al.
Hepatology (Baltimore, Md.)|May 22, 2021
TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard-of-Care TherapyGabriel M Knight, Jeffrey Clark, Justin R Boike, et al.
Radiology|April 25, 2018
Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular CarcinomaRobert J Lewandowski, Ahmed Gabr, Nadine Abouchaleh, et al.
Cardiovascular and Interventional Radiology|February 8, 2020
Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
Cardiovascular and Interventional Radiology|March 3, 2019
Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
Gastroenterology|August 31, 2016
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular CarcinomaRiad Salem, Andrew C Gordon, Samdeep Mouli, et al.
Cardiovascular and Interventional Radiology|April 7, 2021
Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient AnalysisMonica M Matsumoto, Samdeep Mouli, Priyali Saxena, et al.
Hepatology (Baltimore, Md.)|May 17, 2020
Liver Transplantation Following Yttrium-90 Radioembolization: 15-Year Experience in 207-Patient CohortAhmed Gabr, Laura Kulik, Samdeep Mouli, et al.
Hepatology (Baltimore, Md.)|December 2, 2017
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experienceRiad Salem, Ahmed Gabr, Ahsun Riaz, et al.
Pageof 4